Molecule to Market Podcast: M&A Roundtable and 2024 Predictions

Mar 2024

Originally posted by Molecule to Market on March 8, 2024.

James West, Managing Director in Lincoln’s Healthcare Group, recently joined the Molecule to Market podcast’s roundtable episode where he shared an update on the life sciences sector.

Listen to the podcast.



Meet Professionals with Complementary Expertise in Healthcare

Related Perspectives in Healthcare

PETS International | Consolidation Meets Regulation in the Veterinary Clinics Market

Originally posted by PETS International on April 5, 2024. Animal health is becoming a big business in Europe and the U.S. Thus, regulators are turning a closer eye to mergers… Read More

“Leader to Leader” Series

The Leader to Leader video series turns up the dial on rich conversations with prominent leaders – from business owners and entrepreneurs to investors and CEOs – highlighting their stories… Read More

What Price is Right? Trends and Opportunities for Private Equity in Pharma Market Access

The cost of developing new drugs is staggering. Among the top 20 global biopharmas, the average cost of developing a candidate from discovery through clinical trials to market was approximately… Read More

Investment Opportunities in Pharma: A Data-Driven Exploration of CDMO Appeal

The report discusses the current state of the contract development and manufacturing organization (CDMO) market within the pharmaceutical industry, emphasizing the increased interest from private equity (PE) investors. The pharmaceutical… Read More